Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Country/Region
  • No block ID is set

  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
  • Part of brands: |
InternationalInternational
  • Country/Region
  • Part of brands: |
  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
Genomics Precision Diagnostic > Oncology > Gastrointestinal Cancer Precision Panel

Gastrointestinal Cancer Precision Panel

The Igenomix Grastrointestinal Cancer Precision Panel has been designed to carry out an accurate and effective diagnosis of hereditary cancer syndromes involving the organs of the gastrointestinal system. It provides a comprehensive analysis of the most important genes associated with these types of cancer using next-generation sequencing.
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • Gastrointestinal cancer comprises tumours that arise from any part of the gastrointestinal system (esophagus, stomach, duodenum, pancreas, biliary tract, small and large intestines). Hereditary gastrointestinal cancer syndromes due to specific germline variants are characterized by an increased risk of gastrointestinal tract malignancies, extra-gastrointestinal tract cancers, and benign abnormalities. The currently most well-characterized gastrointestinal cancer susceptibility syndromes are: Lynch syndrome, familial adenomatous polyposis, attenuated familial adenomatous polyposis, MUTYH-associated polyposis, Peutz–Jeghers syndrome, juvenile polyposis syndrome, Cowden syndrome, serrated (hyperplastic) polyposis syndrome, hereditary pancreatic cancer, and hereditary gastric cancer. Timely identification of the causative genes help to predict future cancer risks in carriers of germline pathogenic variants and their family members, enabling individualised surveillance recommendations and highly effective risk-reducing measures that ultimately prevent cancer.
  • As many of the oncologists are used to group and study the different cancer types in systems or specialities, the main objective of this product is to provide them with a more manageable diagnostic tool according to their field of knowledge.

Indication

The Igenomix Grastrointestinal Cancer Precision Panel is indicated in those cases in which the physician is suspecting of a hereditary cancer syndrome. It is designed to diagnose adults with a personal or family history suggestive of inherited cancer in an organ of the gastrointestinal system, providing important information that may impact cancer treatment as well as cancer risk assessment and management.

Clinical Utility

The clinical utility of this panel is:  
 
  • Identify pathogenic cancer susceptibility variants
  • Maximize surveillance and preventive strategies for at risk individuals
  • Provide options and strategies for targeted treatment, therapeutic planning, and clinical trials
  • Perform risk assessment and genetic counselling for family members (cascade testing)

Genes & Diseases

Methodology

References

See scientific referrals

Wang, D. K., Zuo, Q., He, Q. Y., & Li, B. (2021). Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications. Frontiers in immunology, 12, 705999. https://doi.org/10.3389/fimmu.2021.705999

Hereditary Gastrointestinal Cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Published in 2019 – Ann Oncol (2019); 00: 1–34

ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes. American Journal of Gastroenterology: February 2015 – Volume 110 – Issue 2 – p 223-262 doi: 10.1038/ajg.2014.435

Hereditary Gastrointestinal Cancer Syndromes: Role of Imaging in Screening, Diagnosis, and Management. https://doi.org/10.1148/rg.2019180185

descargar

Detail description

Download

Request Information

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic testing solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us
Terms and conditions

FOLLOW IGENOMIX

  + 96 390 53 10
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country/Region

[2024] © Igenomix Privacy Page Quality policy Legal note Cookies policy

Request Information


  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
  • Country/Region
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information